NCT04083599 2026-03-16GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid TumorsGenmabPhase 1/2 Active not recruiting350 enrolled
NCT07310784 2026-03-03A Phase II Trial of LM103 in Advanced MelanomaSuzhou BlueHorse Therapeutics Co., Ltd.Phase 2 Recruiting92 enrolled